Skip to main content
. Author manuscript; available in PMC: 2023 Apr 6.
Published in final edited form as: Am J Kidney Dis. 2019 May 14;74(3):328–337. doi: 10.1053/j.ajkd.2019.03.417

Figure 4:

Figure 4:

Figure 4:

Change in kidney function by treatment group.

Panels: (A) Change in creatinine, (B) Change in estimated glomerular filtration rate (eGFR). Bexagliflozin/placebo was dosed through week 24, with an arrow denoting last dose.